60-Year-Olds Double Their Gut Probiotics and Boost Memory After 6 Weeks of Daily Consumption

60-Year-Olds Double Their Gut Probiotics and Boost Memory After 6 Weeks of Daily Consumption

A compound in breast milk called 2′-fucosyllactose (2′-FL) not only helps infants grow but may also improve memory in older adults.
A 2025 study from Stanford University found that supplementing 5 g of 2′-FL daily for six weeks doubled the gut population of Bifidobacteria in elderly participants, while also improving memory and metabolic indicators[1].


2′-FL in Breast Milk

Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk, after lactose and lipids[2].
2′-FL is one of the most abundant HMOs. Composed of lactose linked to fucose, 2′-FL and lacto-N-tetraose are often added to infant formula as key HMO components.

(Figure: Chemical structure of 2′-FL; right: relative abundance of different HMOs in natural breast milk.)


Six Weeks of 2′-FL Boosts Gut Bifidobacteria

To study the physiological effects of 2′-FL in older adults, the Stanford team recruited 89 healthy elderly participants (average age 67), randomly assigning them to three groups:

  • High dose: 5 g/day of 2′-FL

  • Low dose: 1 g/day of 2′-FL

  • Placebo: glucose without 2′-FL

The intervention lasted six weeks, with stool, blood, and urine samples collected to analyze gut microbiota, hormones, and metabolites. After six weeks, supplementation stopped, and follow-up tests were performed.

By the third week, Bifidobacteria counts surged dramatically in the high-dose group and continued increasing until week six. Once supplementation stopped, Bifidobacteria levels returned to baseline.

(Figure: Week 3 showed a sharp rise in Bifidobacteria in the high-dose group.)


What Are Bifidobacteria?

Bifidobacteria are core members of the human gut microbiota, with species composition shifting over a lifetime:

  • Infancy & adolescence (0–17 years): Dominated by B. breve (33%), specialized in breaking down HMOs and supporting neural development[3].

  • Adulthood (18–65 years): B. longum dominates (49%), followed by B. adolescentis (18%), adapted to diverse diets[3].

  • Elderly (66–108 years): B. longum increases to 65%, but species diversity drops sharply, reducing health functions[3].

(Figure: Age-related changes in Bifidobacteria species diversity.)


Metabolic Benefits of 2′-FL

After six weeks of supplementation, elderly participants saw significant increases in two key biomarkers[1]:

  1. HDL cholesterol – the “vascular scavenger,” improving clearance of arterial plaques and reducing atherosclerosis risk.

  2. FGF21 (fibroblast growth factor 21) – a hormone secreted by the liver that regulates lipid metabolism, enhances fat breakdown, and boosts energy expenditure, helping prevent obesity and diabetes[4].

(Figure: Left – HDL increase after 2′-FL; Right – FGF21 increase after 2′-FL.)

However, immune response scores (CRS) did not significantly change across the three groups. CRS is linked to cardiovascular risk and aging, reflecting how quickly immune cells respond to cytokine signals[5].


Why Some Seniors Respond Better

Not all participants benefited equally. Scientists classified those whose Bifidobacteria levels rose above the average as “responders”, and others as “non-responders.”

  • 93.3% of responders already had Bifidobacteria before the trial, compared with 58.6% of non-responders.

  • This suggests baseline presence of Bifidobacteria is key for effective growth after 2′-FL supplementation.

Responders also had higher blood 2′-FL concentrations and greater levels of immune pathway proteins. They showed higher SIRT2 protein levels—associated with anti-aging—than non-responders.

(Figure: Protein and metabolite correlations in responders vs. non-responders.)


2′-FL May Prevent Age-Related Osteoporosis

In aged mice, 12 weeks of 2′-FL supplementation increased bone mineral density (BMD) by ~20%.
While estrogen deficiency is a known osteoporosis driver, gut dysbiosis and immune imbalance are also hidden “bone killers.” 2′-FL improved intestinal barrier integrity, regulated innate immunity, and reduced inflammation that drives bone resorption[7].

(Figure: BMD increase after 12 weeks of 2′-FL in mice.)


Nurturing Gut Microbiota Early Pays Off in Old Age

From the first sip of breast milk, Bifidobacteria play a quiet but vital symphony of symbiosis.
The study shows elderly “responders” (those with baseline Bifidobacteria) benefited more from supplementation—highlighting the long-term value of nurturing gut microbiota early in life.
Caring for your gut flora when young may plant the seeds for health in later years.

 

[1] Carter, M. M., Demis, D., Perelman, D., St Onge, M., Petlura, C., Cunanan, K., Mathi, K., Maecker, H. T., Chow, J. M., Robinson, J. L., Sabag-Daigle, A., Sonnenburg, E. D., Buck, R. H., Gardner, C. D., & Sonnenburg, J. L. (2025). A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults. Cell reports. Medicine, 102256. Advance online publication. https://doi.org/10.1016/j.xcrm.2025.102256
[2] Hill, D. R., Chow, J. M., & Buck, R. H. (2021). Multifunctional Benefits of Prevalent HMOs: Implications for Infant Health. Nutrients, 13(10), 3364. https://doi.org/10.3390/nu13103364
[3] Wei, X., Yu, L., Zhang, C., Ni, Y., Zhang, H., Zhai, Q., & Tian, F. (2023). Genetic-Phenotype Analysis of Bifidobacterium bifidum and Its Glycoside Hydrolase Gene Distribution at Different Age Groups. Foods (Basel, Switzerland), 12(5), 922. https://doi.org/10.3390/foods12050922
[4] Li, X., Rao, Z., Hu, W., Lu, W., & Luo, Y. (2025). Treating metabolic dysfunction-associated steatohepatitis: The fat-trimming FGF21 approach. Obesity reviews : an official journal of the International Association for the Study of Obesity, 26(3), e13861. https://doi.org/10.1111/obr.13861
[5] Shen-Orr, S. S., Furman, D., Kidd, B. A., Hadad, F., Lovelace, P., Huang, Y. W., Rosenberg-Hasson, Y., Mackey, S., Grisar, F. A., Pickman, Y., Maecker, H. T., Chien, Y. H., Dekker, C. L., Wu, J. C., Butte, A. J., & Davis, M. M. (2016). Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans. Cell systems, 3(4), 374–384.e4. https://doi.org/10.1016/j.cels.2016.09.009
[6] Berger, P. K., Plows, J. F., Jones, R. B., Alderete, T. L., Yonemitsu, C., Poulsen, M., Ryoo, J. H., Peterson, B. S., Bode, L., & Goran, M. I. (2020). Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers. PloS one, 15(2), e0228323. https://doi.org/10.1371/journal.pone.0228323
[7] Li, A., Kou, R., Wang, J., Zhang, B., Zhang, Y., Liu, J., Hu, Y., & Wang, S. (2024). 2'-Fucosyllactose ameliorates aging-related osteoporosis by restoring gut microbial and innate immune homeostasis. Journal of advanced research, S2090-1232(24)00536-8. Advance online publication. https://doi.org/10.1016/j.jare.2024.11.017
Back to blog

Leave a comment

Please note, comments need to be approved before they are published.